Literature DB >> 26450558

Erratum to: Multicentre randomized controlled trial comparing ferric(III) carboxymaltose infusion with oral iron supplementation in the treatment of preoperative anaemia in colorectal cancer patients.

W A A Borstlap1, C J Buskens2, K M A J Tytgat3, J B Tuynman4, E C J Consten5, R C Tolboom5, G Heuff6, A A W van Geloven7, B A van Wagensveld8, C A C A Wientjes9, M F Gerhards10, S M M de Castro10, J Jansen11, A W H van der Ven12, E van der Zaag13, J M Omloo13, H L van Westreenen14, D C Winter15, R P Kennelly15, M G W Dijkgraaf16, P J Tanis2, W A Bemelman2.   

Abstract

Entities:  

Year:  2015        PMID： 26450558      PMCID： PMC4599035          DOI： 10.1186/s12893-015-0090-5

Source DB:  PubMed          Journal:  BMC Surg        ISSN： 1471-2482            Impact factor:   2.102


× No keyword cloud information.
Erratum to: BMC Surgery doi:10.1186/s12893-015-0065-6 Following publication of the original version of this article in BMC Surgery [1] it was brought to our attention that the name of one author was spelled incorrectly. The name of author A.A.W. van Geloven was incorrectly spelled as ‘N. van Geloven’.
  1 in total

1.  Multicentre randomized controlled trial comparing ferric(III)carboxymaltose infusion with oral iron supplementation in the treatment of preoperative anaemia in colorectal cancer patients.

Authors:  W A A Borstlap; C J Buskens; K M A J Tytgat; J B Tuynman; E C J Consten; R C Tolboom; G Heuff; N van Geloven; B A van Wagensveld; C A C A Wientjes; M F Gerhards; S M M de Castro; J Jansen; A W H van der Ven; E van der Zaag; J M Omloo; H L van Westreenen; D C Winter; R P Kennelly; M G W Dijkgraaf; P J Tanis; W A Bemelman
Journal:  BMC Surg       Date:  2015-06-28       Impact factor: 2.102
  1 in total
  1 in total

1.  Erythropoietin for cancer-associated malignant anemia: A meta-analysis.

Authors:  Feng Zhao; Yijuan Wang; Lin Liu; Meiling Bian
Journal:  Mol Clin Oncol       Date:  2017-05-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.